Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kees

Showing results (121-130 of 376) with videos related to

Pageof 38
Sort By:
European Heart Journal|April 6, 2016
Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemiaJoost Besseling, Johannes B Reitsma, Daniel Gaudet, et al.
Journal of Pharmaceutical Sciences|September 21, 2017
Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by UltrafiltrationChristoph Dorn, Alexander Kratzer, Uwe Liebchen, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2013
Plasma amyloid-β in patients with Tangier diseasePashtun Shahim, Andrea E Bochem, Niklas Mattsson, et al.
Current Opinion in Lipidology|July 10, 2004
CETP gene variation: relation to lipid parameters and cardiovascular riskS Matthijs Boekholdt, Jan-Albert Kuivenhoven, G Kees Hovingh, et al.
Heart (British Cardiac Society)|January 18, 2015
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial diseaseRobert M Stoekenbroek, S Matthijs Boekholdt, Rana Fayyad, et al.
Scientific Reports|October 28, 2017
Effects of Supra-Physiological Levothyroxine Dosages on Liver Parameters, Lipids and Lipoproteins in Healthy Volunteers: A Randomized Controlled Crossover StudyBarbara Sjouke, Laura P B Elbers, Bregje van Zaane, et al.
Critical Care (London, England)|December 19, 2018
Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic studyA Broeker, S G Wicha, C Dorn, et al.
Circulation|June 17, 2004
Measurement of arterial wall thickness as a surrogate marker for atherosclerosisEric de Groot, G Kees Hovingh, Albert Wiegman, et al.
Current Opinion in Lipidology|November 21, 2002
Measurement of subclinical atherosclerosis: beyond risk factor assessmentRadjesh J Bisoendial, G Kees Hovingh, Eric de Groot, et al.
European Journal of Preventive Cardiology|July 23, 2021
Next-generation sequencing to confirm clinical familial hypercholesterolemiaLaurens F Reeskamp, Tycho R Tromp, Joep C Defesche, et al.
Pageof 38

Showing results (121-130 of 376) with videos related to

Sort By:
Pageof 38
European Heart Journal|April 6, 2016
Selection of individuals for genetic testing for familial hypercholesterolaemia: development and external validation of a prediction model for the presence of a mutation causing familial hypercholesterolaemiaJoost Besseling, Johannes B Reitsma, Daniel Gaudet, et al.
Journal of Pharmaceutical Sciences|September 21, 2017
Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by UltrafiltrationChristoph Dorn, Alexander Kratzer, Uwe Liebchen, et al.
Journal of Alzheimer'S Disease : JAD|February 8, 2013
Plasma amyloid-β in patients with Tangier diseasePashtun Shahim, Andrea E Bochem, Niklas Mattsson, et al.
Current Opinion in Lipidology|July 10, 2004
CETP gene variation: relation to lipid parameters and cardiovascular riskS Matthijs Boekholdt, Jan-Albert Kuivenhoven, G Kees Hovingh, et al.
Heart (British Cardiac Society)|January 18, 2015
High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial diseaseRobert M Stoekenbroek, S Matthijs Boekholdt, Rana Fayyad, et al.
Scientific Reports|October 28, 2017
Effects of Supra-Physiological Levothyroxine Dosages on Liver Parameters, Lipids and Lipoproteins in Healthy Volunteers: A Randomized Controlled Crossover StudyBarbara Sjouke, Laura P B Elbers, Bregje van Zaane, et al.
Critical Care (London, England)|December 19, 2018
Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic studyA Broeker, S G Wicha, C Dorn, et al.
Circulation|June 17, 2004
Measurement of arterial wall thickness as a surrogate marker for atherosclerosisEric de Groot, G Kees Hovingh, Albert Wiegman, et al.
Current Opinion in Lipidology|November 21, 2002
Measurement of subclinical atherosclerosis: beyond risk factor assessmentRadjesh J Bisoendial, G Kees Hovingh, Eric de Groot, et al.
European Journal of Preventive Cardiology|July 23, 2021
Next-generation sequencing to confirm clinical familial hypercholesterolemiaLaurens F Reeskamp, Tycho R Tromp, Joep C Defesche, et al.
Pageof 38